These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22107175)
1. Development and optimization of lyophilized orally disintegrating tablets using factorial design. Ahmed IS; Shamma RN; Shoukri RA Pharm Dev Technol; 2013; 18(4):935-43. PubMed ID: 22107175 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Shoukri RA; Ahmed IS; Shamma RN Eur J Pharm Biopharm; 2009 Sep; 73(1):162-71. PubMed ID: 19406232 [TBL] [Abstract][Full Text] [Related]
3. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963 [TBL] [Abstract][Full Text] [Related]
4. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone. Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin. Ahmed IS; Aboul-Einien MH Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451 [TBL] [Abstract][Full Text] [Related]
6. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride. Stange U; Führling C; Gieseler H J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095 [TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression. Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682 [TBL] [Abstract][Full Text] [Related]
8. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers. Dhumal RS; Shimpi SL; Paradkar AR Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109 [TBL] [Abstract][Full Text] [Related]
9. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method. Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500 [TBL] [Abstract][Full Text] [Related]
10. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. Dehghani H; Taheri A; Homayouni A Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108 [TBL] [Abstract][Full Text] [Related]
11. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design. Aboelwafa AA; Fahmy RH Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483 [TBL] [Abstract][Full Text] [Related]
12. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. Gohel M; Patel M; Amin A; Agrawal R; Dave R; Bariya N AAPS PharmSciTech; 2004 Apr; 5(3):e36. PubMed ID: 15760070 [TBL] [Abstract][Full Text] [Related]
13. Fast and pH-dependent release of domperidone from orally disintegrating tablets. Assaf SM; Qandil AM; Al-Ani EA Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659 [TBL] [Abstract][Full Text] [Related]
14. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. Rahman Z; Zidan AS; Khan MA Int J Pharm; 2010 Nov; 400(1-2):49-58. PubMed ID: 20801200 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050 [TBL] [Abstract][Full Text] [Related]
16. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation. Rahman Z; Siddiqui A; Khan MA Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704 [TBL] [Abstract][Full Text] [Related]
17. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process. Elnaggar YS; El-Massik MA; Abdallah OY; Ebian AE AAPS PharmSciTech; 2010 Jun; 11(2):645-51. PubMed ID: 20405257 [TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets. Malladi M; Jukanti R; Nair R; Wagh S; Padakanti HS; Mateti A Acta Pharm; 2010 Sep; 60(3):267-80. PubMed ID: 21134862 [TBL] [Abstract][Full Text] [Related]
19. A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study. Teaima MH; Abdel-Haleem KM; Osama R; El-Nabarawi MA; Elnahas OS Drug Des Devel Ther; 2021; 15():4229-4242. PubMed ID: 34675486 [TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin. Ge Z; Yang M; Wang Y; Shan L; Gao C Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]